Experts believe the model could improve risk stratification and offer patients more personalized screening strategies. 

Here’s a big thing to watch for in the wake of the President’s flashy Middle East tour: the AI “acceleration partnership” between the U.S. and the United Arab Emirates. 

Advocate, Memorial Hermann, Corewell, and Atlantic Health System are together contributing $8 million in “strategic” investments with the San Francisco company. 

When paired with willing older adults, talking AI can administer and assess preliminary dementia tests in much the same way—and with similar effectiveness—as human specialists.

Report errors can result in incorrect or delayed diagnoses and significantly impact disease management. 

John Simon, MD, is a big advocate for these elective exams, but the American College of Radiology and some members of the specialty oppose this practice. 

Clinical validation testing proved CleaRecon DL’s 3D image reconstructions to be effective at reducing unwanted artifacts, offering clearer images in 98% of cases.

Researchers have used a state-of-the-art microscope and advanced AI to track clotting risks in CAD patients. The goal is to spot blood clots before they even happen, ensuring patients are prescribed the right therapy for their specific needs.